Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
dodekin (F8-IL12) / Philogen
DODEKA, NCT04471987: Safety and Early Signs of Efficacy of IL12-L19L19.	Recruiting	1	94	Europe	IL12-L19L19, Dodekin	Philogen S.p.A.	Advanced Solid Tumor, Metastatic Solid Tumor	12/25	12/25